Cardlytics Inc. said late Thursday that it plans to price its initial public offering at $13 a share, at the low end of its range, and raise $70.2 million. The purchase intelligence platform will offer 5.4 million shares and list on the Nasdaq under the ticker symbol “CDLX.” BofA Merrill Lynch and J.P. Morgan are joint book-runners for the IPO. In the nine months ending in September, Cardlytics logged losses of $16 million on sales of $91 million.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News